Acetyl-Leucine Treatment for Age-Related Mobility and Cognition

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There are few therapeutic options available to address age-related mobility and cognitive decline in elderly individuals, and existing treatments for conditions like vertigo do not effectively improve mobility and cognitive function in otherwise healthy aging individuals.

Innovation Solution

Acetyl-leucine or its pharmaceutically acceptable salts are administered to improve mobility and cognitive function in elderly subjects, with doses ranging from 1.5 g to 10 g per day, typically in multiple administrations over several weeks or months.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If acetyl-leucine is administered to improve cognitive function and mobility in elderly subjects, then cognitive function and mobility are significantly improved, but the treatment requires high doses (1.5g to 10g per day) and long duration (weeks to months)

Engineering Contradiction:

Improvecognitive function and mobility improvementVSAvoiddose and treatment duration

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The patent changes the chemical parameter by using acetyl-leucine (an N-acetyl amino acid) instead of conventional vertigo treatments. This chemical modification enables the substance to cross the blood-brain barrier and affect central nervous system function, thereby improving cognitive function and mobility at relatively high doses over extended periods

Inventive Principle:

Principle #35Parameter changes

2Reliability

If conventional vertigo treatments are used, then vertigo symptoms may be addressed, but they do not effectively improve mobility and cognitive function in otherwise healthy aging individuals

Engineering Contradiction:

Improvemobility and cognitive function improvementVSAvoidapplicability to healthy aging individuals

Core Design Contradiction:

ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent makes the treatment universal by demonstrating that acetyl-leucine benefits not only vertigo patients but also otherwise healthy elderly individuals experiencing age-related cognitive decline and mobility reduction. The substance performs multiple functions: treating vertigo, improving cognitive function, and enhancing mobility across different patient populations

Inventive Principle:

Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250332133A1Acetyl-leucine or a pharmaceutically acceptable salt thereof for improved mobility and cognitive function

Publication Date: 2025.10.30 INTRABIO LTD

AI summary

The present disclosure is directed to acetyl-leucine or a pharmaceutically acceptable salt thereof for use in improving cognitive function, mobility, or cognitive function and mobility in a subject, for example, in an elderly subject.